Autres langues Bicycle Therapeutics plc

Actions

BCYC

US0887861088

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 21/08/2026			Varia. 5j.	Varia. 1 janv.
4,370 ^USD	+3,07%		+12,05%	-38,28%

21/08	Les actions européennes cotées aux États-Unis sous forme d'ADR s'inscrivent en hausse lors de la séance de vendredi	MT
19/08	Les actions européennes cotées aux États-Unis sous forme d'ADR progressent lors de la séance de mercredi	MT

Autres langues

21/08	European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading
19/08	European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
17/08	European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading
14/08	European Equities Traded in the US as American Depositary Receipts Track Lower in Friday Trading
07/08	European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
30/07	Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results
30/07	Bicycle Therapeutics plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
24/07	European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
30/06	European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
22/06	Bicycle Therapeutics plc Announces Termination of Janice Bourque from Director Role, Effective June 17, 2026
22/06	Bicycle Therapeutics plc Announces Termination of Sir Gregory Paul Winter from Director Role, Effective June 17, 2026
17/06	European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
16/06	European Equities Traded in the US as American Depositary Receipts Slightly Higher in Tuesday Trading
02/06	European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
22/05	European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
21/05	Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting
21/05	Bicycle Therapeutics plc Presents Initial Duravelo-2 Data At 2026 Asco Annual Meeting
07/05	European Equities Traded in the US as American Depositary Receipts Heading Lower in Thursday Trading
01/05	European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading; Gain 1.3% for Week
30/04	European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
30/04	Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results
30/04	Bicycle Therapeutics plc Reports Earnings Results for the First Quarter Ended March 31, 2026
21/04	Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting
20/04	Bicycle Therapeutics plc Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline
20/04	Bicycle Therapeutics : April 2026 Corporate Presentation